Navigation Links
UC Riverside entomologists say biocontrol of insect pest in the Galapagos Islands is a major success
Date:4/22/2010

e collapsing because of feeding by larval and adult lady bug beetles. Our project was to follow up to see whether the lady bug beetle in 2009 was still exerting high levels of control over the cottony cushion scale and whether the project was safe as predicted by lab studies."

After about three months of survey work Hoddle, along with Christina Hoddle (UCR), Charlotte Causton (Charles Darwin Research Station), and Roy Van Driesche (University of Massachusetts, Amherst), concluded that the cottony cushion scale populations were very low in most areas on the Galapagos Islands.

"Pest numbers have been reduced by more than 99 percent on some native plants like mangroves, which were very susceptible to attack by cottony cushion scale," Hoddle said. "While from other rarer native plants, like Darwiniothamnus tenuifolius, the pest appears to have been completely removed."

To assess the impact of the beetle on the cottony cushion scale, Hoddle's team surveyed native plants across five different islands Santa Cruz, Isabela, Espanola, San Cristobal, and Santiago and recorded the presence and absence of cottony cushion scale and the lady bug beetle, and their densities. The team then compared the data to similar data from the same areas and in many instances, from the very same trees that had been collected before the lady bug beetle was released into the Galapagos.

"We also found no evidence that the lady bug beetle was attacking non-target species," Hoddle said. "The bug was never seen feeding on other insects in the Galapagos even when the cottony cushion scale and the non-target species were side by side on the same twig."

The cottony cushion scale project with the beetle was born in Southern California in 1888-1889 and saved California's then fledging citrus industry.

"The project in the Galapagos is an extension of the California success story," Hoddle said. "But in the Galapagos the biocontrol agent is p
'/>"/>

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. UC Riverside entomologist recognized for research in citrus entomology
2. UC Riverside lecture: Climate change, bark beetles, environmental markets and sustainability
3. UC Riverside to host 3-day international meeting on drought
4. UC Riverside licenses technology to OlFactor Laboratories, Inc.
5. UC Riversides new state-of-the-art technology to accelerate stem cell research
6. Evolution impacts environment, challenging traditionally held view, UC Riverside study finds
7. UC Riverside biologist is invited speaker at TED Conference
8. UC Riverside plant scientists research ranked on top ten breakthrough list for 2009
9. Kornberg Associates
10. Architects Completes UC Riverside Stem Cell Core Facility Project
11. Evolution of hyperactivity is focus of free public lecture at UC Riverside
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UC Riverside entomologists say biocontrol of insect pest in the Galapagos Islands is a major success
(Date:6/24/2015)... Biometry authentication provider KeyLemon today announced ... one face in. Logo - ... in, entering the expanding biometric authentication market in ... answer to the password problem. With advanced face ... KeyLemon, one face in allows users to securely ...
(Date:6/23/2015)... N.C. , June 23, 2015   ... today announced the results of a recent study ... accuracy on the wrist during activity. In a ... technology was compared along with the Apple Watch ... accurately measuring heart rate during activity. The study ...
(Date:6/18/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... market announces that its Wocket® smart wallet will be the ... scheduled to air on WABC Radio (am770) in ... The broadcast air- time for the extensive one ... Inc.,s CEO Gino Pereira will be discussing its ...
Breaking Biology News(10 mins):KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
... scientific basis for eventual treatment, neurology researchers have shown ... protein that helps keep brain activity in balance. The ... an underlying reason for seizures and memory defects experienced ... (TBI). , "A traumatic brain injury occurs to someone ...
... an immune response against HIV, research funded by the Wellcome ... in the US has found that bigger is not necessarily ... a profound impact on the development of a vaccine against ... bigger the immune response, the more effective it will be ...
... Scientists have discovered that autoimmunity can be triggered in the ... cells fail to recognize just one of the body's thousands ... view that autoimmunity can start in this cradle of the ... diseases emerge, such as the pancreas in the case of ...
Cached Biology News:How brain injury leads to seizures, memory problems 2Quality not quantity important for immune response to HIV 2Autoimmune disease triggered if T cells miss a single protein early on 2Autoimmune disease triggered if T cells miss a single protein early on 3
(Date:7/6/2015)... , July 6, 2015  Emdeon Inc. ... a definitive agreement to acquire Altegra Health, ... platforms that combine data aggregation and analytics ... to achieve actionable insights and improved management ... Altegra Health,s risk adjustment and quality analytics ...
(Date:7/6/2015)... 2015  Viveve Medical, Inc. ("Viveve") (OTCQB: VIVMF), a company focused ... Viveve,s Chief Executive Officer, and Scott Durbin , Viveve,s ... 9, 2015. , , , DATE:    , ... , TIME:     , , , 12:15 PM EDT ... http://tinyurl.com/viveve   ,    ...
(Date:7/5/2015)... ... 06, 2015 , ... For many years, metal-on-quartz filters were the industry standard ... as a Varian Cary 4000-7000, a Perkin Elmer 800-1100 or a Shimadzu 3600-3700, these ... used them for their SRM-2031 series going back for many years. Unfortunately, these standards ...
(Date:7/3/2015)... , ... July 03, 2015 , ... ... by Fortune 500 companies and professional service industries alike-- typically known for its ... clients laugh, honor a good cause and break from their day jobs. , ...
Breaking Biology Technology:Emdeon to Acquire Altegra Health 2Emdeon to Acquire Altegra Health 3Emdeon to Acquire Altegra Health 4Viveve to Webcast Live at VirtualInvestorConferences.com 2Viveve to Webcast Live at VirtualInvestorConferences.com 3FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 2FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 3The Alexander Group Declares Their Independence with a Bit of Levity 2
... , , SOUTH SAN FRANCISCO, ... today announced that 320 evaluable events (patient deaths) have occurred in its ... is being conducted in accordance with a Special Protocol Assessment (SPA) with ... of small cell lung cancer (SCLC). , , ...
... WOBURN, Mass., Sept. 15 BioVex Inc, a biotechnology ... infectious disease, announced today that the U.S. Food and Drug Administration ... clinical trial evaluating its lead product, OncoVEX (GM-CSF), for the first-line ... neck. , , The study is the ...
... , SAN DIEGO, Sept. 15 ... with China, today announced a strategic partnership agreement with Guangzhou ... HUYA has established a series of strategic partnerships with Chinese ... portfolio of novel biopharmaceutical products. The agreement with GIBH provides ...
Cached Biology Technology:Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 2Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 3Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 4Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 5BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX (GM-CSF) in Head and Neck Cancer 2BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX (GM-CSF) in Head and Neck Cancer 3BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX (GM-CSF) in Head and Neck Cancer 4HUYA Bioscience Establishes First-Look Agreement With Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH) 2HUYA Bioscience Establishes First-Look Agreement With Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH) 3
Anti-G-alpha-i 1 G-Protein Host: mouse monoclonal Species Reactivity: human, mouse, rat Applications: WB Storage: 4C...
WIF-1 (N-20)...
Mouse monoclonal [1.T.4] to WAVE 1 ( Abpromise for all tested applications). Antigen: His6 fusion protein corresponding to full-length rat WAVE1. Entrez Gene ID: 8936...
IgG2b, k APC clone A95-1, Isotype Rat IgG2b, kappa, 0.1 mg ....
Biology Products: